Press Releases Seegene, Inc.

Equities

A096530

KR7096530001

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
22,400 ^KRW	+2.52%		+0.22%	-2.18%

Mar. 14	Seegene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 24	Seegene Inc. Announces Collaboration with Microsoft to Realize a World Free from All Diseases	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Seegene and UK Health Security Agency convene a summit to collectively realize 'a World Free from All Diseases'	Apr. 09	AQ
Seegene and UK Health Security Agency convene a summit to collectively realize "a World Free from All Diseases"	Apr. 08	AQ
Seegene and Springer Nature Announce Awardees for the Open Innovation Program	Mar. 15	AQ
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases'	Jan. 24	AQ
Seegene obtains ISO45001 certification	Dec. 27	AQ
Seegene Earns Improved ESG Rating from the Korea Institute of Corporate Governance and Sustainability	Nov. 10	AQ
Seegene Unveils 'Open Innovation Program Powered by Seegene' in Partnership with Springer Nature	23-09-04	AQ
Seegene declares to share Syndromic PCR technologies to prevent future pandemics	23-03-28	AQ
Seegene reports H1 2022 financial results	22-08-12	AQ
Seegene unveils strategies for global expansion at 2022 AACC	22-07-29	AQ
Seegene launches world's first In-life PCR campaign in Vietnam	22-07-19	AQ
Seegene to pave way for PCR testing at local clinics with EU-approved multiplex test and fully automated PCR solution	22-06-29	AQ
Seegene develops PCR test to detect monkeypox virus	22-06-28	AQ
Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic	22-05-25	AQ
Seegene reports first quarter 2022 financial results	22-05-13	AQ
Seegene unveils world's first commercialized '3 Ct' PCR assay	22-04-26	AQ
Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary	22-03-17	AQ
Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business	22-03-02	AQ
Seegene unveils new assay optimized for on-site testing in 'living with Covid-19' era	22-02-24	AQ
Seegene Announces Q4 and Full-Year 2021 Financial Results	22-02-17	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Seegene, Inc.

Equities

A096530

KR7096530001

Press Releases

Filters